Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wilms' tumor

M J Petruzzi1, D M Green

  • 1Department of Pediatrics, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, USA.

Pediatric Clinics of North America
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Wilms tumor, a common childhood kidney cancer, has high survival rates for favorable cases. Advances in molecular genetics are revealing key genetic factors in its development and normal kidney growth.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The birthday problem: repeated sampling of animal populations and ethics of experimental design.

Animal : an international journal of animal bioscience·2024
Same author

In vitro human skin absorption of linalool: Effects of vehicle composition, evaporation and occlusion on permeation and distribution.

International journal of pharmaceutics·2022
Same author

The contact structure of Great Britain's salmon and trout aquaculture industry.

Epidemics·2019
Same author

Identifying genotype specific elevated-risk areas and associated herd risk factors for bovine tuberculosis spread in British cattle.

Epidemics·2018
Same author

Heterogeneous responses of temperate-zone amphibian populations to climate change complicates conservation planning.

Scientific reports·2017
Same author

Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study.

Journal of cancer survivorship : research and practice·2014
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Area of Science:

  • Pediatric Oncology
  • Molecular Genetics
  • Developmental Biology

Background:

  • Wilms tumor is the predominant renal malignancy in children.
  • Favorable histology Wilms tumor exhibits survival rates nearing 90%.
  • Understanding the genetic underpinnings is crucial for therapeutic advancements.

Purpose of the Study:

  • To explore the genetic factors contributing to Wilms tumor development.
  • To investigate the molecular mechanisms of normal renal development.
  • To elucidate the processes of tumorigenesis in Wilms tumor.

Main Methods:

  • Review of recent molecular genetics research.
  • Analysis of genetic mutations and pathways.
  • Comparative studies of tumor and normal kidney tissue.

Related Experiment Videos

Main Results:

  • Identification of key genes and mutations associated with Wilms tumor.
  • Insights into disrupted developmental pathways.
  • Elucidation of tumorigenesis mechanisms.

Conclusions:

  • Molecular genetics provides critical understanding of Wilms tumor.
  • Genetic insights pave the way for targeted therapies.
  • Further research can improve pediatric cancer treatment outcomes.